Related references
Note: Only part of the references are listed.Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: Discovery and structure-activity relationships
Bo Ren et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Preclinical and clinical role of interleukin-6 in the development of delayed cerebral vasospasm and neuronal cell death after subarachnoid hemorrhage: towards a potential target therapy?
Davide Marco Croci et al.
NEUROSURGICAL REVIEW (2022)
Brain-associated innate leukocytes display diverse inflammatory states following experimental stroke
Brooke J. Wanrooy et al.
IMMUNOLOGY AND CELL BIOLOGY (2022)
JNK selective inhibitor, IQ-1S, protects the mice against lipopolysaccharides-induced sepsis
Zhelong Nie et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
r2SCAN-3c: A Swiss army knife composite electronic-structure method
Stefan Grimme et al.
JOURNAL OF CHEMICAL PHYSICS (2021)
Deep learning identifies synergistic drug combinations for treating COVID-19
Wengong Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Lithium beyond psychiatric indications: the reincarnation of a new old drug
Matteo Haupt et al.
NEURAL REGENERATION RESEARCH (2021)
Arene-Ruthenium(II) Complexes Containing 11H-Indeno[1,2-b]quinoxalin-11-one Derivatives and Tryptanthrin-6-oxime: Synthesis, Characterization, Cytotoxicity, and Catalytic Transfer Hydrogenation of Aryl Ketones
Vladislava V. Matveevskaya et al.
ACS OMEGA (2020)
Synthesis, characterization, biological activity and electrochemistry studies of iron(III) complex with curcumin-oxime ligand
Guluzar Ozbolat et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
Neuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia
Mark B. Plotnikov et al.
CELLS (2020)
The ORCA quantum chemistry program package
Frank Neese et al.
JOURNAL OF CHEMICAL PHYSICS (2020)
Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Catherine Owens Johnson et al.
LANCET NEUROLOGY (2019)
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats
Mark B. Plotnikov et al.
MOLECULES (2019)
The impact of sex and age on T cell immunity and ischemic stroke outcomes
Hilda Ahnstedt et al.
CELLULAR IMMUNOLOGY (2019)
The Involvement and Therapy Target of Immune Cells After Ischemic Stroke
Zhihong Jian et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Role of Inflammatory Response in Stroke Associated Programmed Cell Death
K. Duris et al.
CURRENT NEUROPHARMACOLOGY (2018)
Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke
Xinzhi Chen et al.
NEUROMOLECULAR MEDICINE (2018)
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury
Maria Shvedova et al.
FRONTIERS IN PHARMACOLOGY (2018)
Tyrosol attenuates pro-inflammatory cytokines from cultured astrocytes and NF-kappa B activation in in vitro oxygen glucose deprivation
Gang Luo et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and infl ammation
Angel Chamorro et al.
LANCET NEUROLOGY (2016)
A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia-reperfusion injury in mice
Dmitriy N. Atochin et al.
NEUROSCIENCE LETTERS (2016)
Clinical Trials of Immunomodulation in Ischemic Stroke
Roland Veltkamp et al.
NEUROTHERAPEUTICS (2016)
Inflammation and Stroke: An Overview
Josef Anrather et al.
NEUROTHERAPEUTICS (2016)
c-Jun N-terminal kinase inhibitors: a patent review (2010-2014)
Matthias Gehringer et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Inhibitors of c-Jun N-Terminal Kinases: An Update
Pierre Koch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor
Igor A. Schepetkin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
The Effect of Lithium in Post-Stroke Motor Recovery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Seyed Ehsan Mohammadianinejad et al.
CLINICAL NEUROPHARMACOLOGY (2014)
Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation
Mingjin Jiang et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Impact of an immune modulator fingolimod on acute ischemic stroke
Ying Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Systematic Review and Meta-Analysis of the Efficacy of Sphingosine-1-Phosphate (S1P) Receptor Agonist FTY720 (Fingolimod) in Animal Models of Stroke
Junfeng Liu et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2013)
Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies
Clare Davies et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Delayed Inhibition of c-Jun N-Terminal Kinase Worsens Outcomes after Focal Cerebral Ischemia
Yoshihiro Murata et al.
JOURNAL OF NEUROSCIENCE (2012)
Identification and Characterization of a Novel Class of c-Jun N-terminal Kinase Inhibitors
Igor A. Schepetkin et al.
MOLECULAR PHARMACOLOGY (2012)
Synergistic effects of prostaglandin E1 and lithium in a rat model of cerebral ischemia
Rong Han et al.
ACTA PHARMACOLOGICA SINICA (2008)
AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils
S. Carboni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia
Young R. Kim et al.
STROKE (2008)
Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils
Qingming Bian et al.
BRAIN RESEARCH (2007)
Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia
Xue-Bo Yan et al.
NEUROPHARMACOLOGY (2007)
Greater stress protein expression enhanced by combined prostaglan-din A1 and lithium in a rat model of focal ischemia
Xi-hui Xu et al.
ACTA PHARMACOLOGICA SINICA (2007)
The functional contrariety of JNK
Ann M. Bode et al.
MOLECULAR CARCINOGENESIS (2007)
Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia
Xue-Bo Yan et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Molecular targets in cerebral ischemia for developing novel therapeutics
Suresh L. Mehta et al.
BRAIN RESEARCH REVIEWS (2007)
Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia
Xi-Hui Xu et al.
BRAIN RESEARCH (2006)
MolDock: A new technique for high-accuracy molecular docking
Rene Thomsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis
Qiu-Hua Guan et al.
BRAIN RESEARCH (2006)
Quantum mechanical continuum solvation models
J Tomasi et al.
CHEMICAL REVIEWS (2005)
Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway
YQ Gao et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: Protection by mood stabilizers and imipramine
MS Roh et al.
BIOLOGICAL PSYCHIATRY (2005)
Targeting the JNK Signaling Pathway for Stroke and Parkinson's Diseases Therapy
Chia-Yi Kuan et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Specific pathophysiological functions of JNK isoforms in the brain
S Brecht et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia
J Ma et al.
NEUROSCIENCE RESEARCH (2004)
Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia
J Ma et al.
NEUROSCIENCE LETTERS (2003)
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
T Borsello et al.
NATURE MEDICINE (2003)
Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model
M Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death
JH Xu et al.
STROKE (2003)
Role of mitogen- and stress-activated kinases in ischemic injury
EA Irving et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Neuroprotective effects of lithium in cultured cells and animal models of diseases
DM Chuang et al.
BIPOLAR DISORDERS (2002)
Toll-like receptors; their physiological role and signal transduction system
O Takeuchi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
LPS induction of gene expression in human monocytes
M Guha et al.
CELLULAR SIGNALLING (2001)
Signal transduction by the JNK group of MAP kinases
RJ Davis
CELL (2000)
c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion
T Hayashi et al.
NEUROSCIENCE LETTERS (2000)
Share Paper
